Activists Across the World Demand Urgent Action to Improve Access to Lifesaving Tuberculosis (TB) Medicine, Bedaquiline
Call to action Medicine Equality Now! Public StatementJuly 1, 2022 – A new generic version of bedaquiline produced by Macleods Pharmaceuticals in India has cleared the Global...
Indonesia Issues Government Use Licenses for Remdesivir and Favipiravir
Medicine Equality Now! NewsMake Medicines Affordable Campaign and ITPC welcome the Presidential Decrees issued in Indonesia for government use licenses on remdesivir and...
Read more about Indonesia Issues Government Use Licenses for Remdesivir and Favipiravir
MMA’s partners in Kazakhstan call for systemic changes to the country’s intellectual property and access to medicines framework in their annual report
News ResearchAnswer Foundation and Antihepatitis C Foundation, MMA’s partners in Kazakhstan, with technical support from ITPC-Ru, recently launched a comprehensive Annual...
COVID-19 pandemic: ‘An opportunity of a lifetime’?
News Research The race is on to find an effective treatment and vaccine for COVID-19. Everyone hopes a solution will be...
Read more about COVID-19 pandemic: ‘An opportunity of a lifetime’?
Possible treatments for COVID-19 could all be made for $1 a day, say researchers: Pharma must not profit from a pandemic and countries must ACT NOW.
Call to action News ResearchDrugs currently being used in COVID-19 treatment trials can all be mass-produced affordably, research from the University of Liverpool, published...
Open letter: COVID-19 underlines the need for 37 World Trade Organization members to reverse a critical decision
Call to action NewsAs the International Treatment Preparedness Coalition (ITPC), we have signed an open letter asking 37 World Trade Organization members to...
We can’t end AIDS without tackling patent abuse
News OpinionDespite significant scientific advancements for HIV, along with global and national commitments to ‘end AIDS’, hundreds of thousands of people...
Read more about We can’t end AIDS without tackling patent abuse
The right to health is compulsory: Time for action on dolutegravir – now!
Call to action News ResearchWhy Algeria, Azerbaijan, Belarus, Brazil, Bulgaria, China, Colombia, Kazakhstan, Mexico, Romania, Russia, and Turkey must issue compulsory licences on dolutegravir...
Read more about The right to health is compulsory: Time for action on dolutegravir – now!